FIG. 7.
(a)–(h) Confluent EC in the device subjected to a 3-day treatment of different concentrations of paclitaxel. (i) Relative viability of EC after 3-days of exposure to different concentrations of paclitaxel treatment.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.